These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 31519475

  • 21. Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.
    Gaston TE, Bebin EM, Cutter GR, Ampah SB, Liu Y, Grayson LP, Szaflarski JP, UAB CBD Program.
    Epilepsy Behav; 2019 Sep; 98(Pt A):201-206. PubMed ID: 31382177
    [Abstract] [Full Text] [Related]

  • 22. A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.
    VanLandingham KE, Crockett J, Taylor L, Morrison G.
    J Clin Pharmacol; 2020 Oct; 60(10):1304-1313. PubMed ID: 32652616
    [Abstract] [Full Text] [Related]

  • 23. Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    García-Peñas JJ, Gil Nagel-Rein A, Sánchez-Carpintero R, Villanueva-Haba V.
    Rev Neurol; 2021 Sep 10; 73(S01):S1-S8. PubMed ID: 34486101
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome.
    Johannessen Landmark C, Heger K, Lund C, Burns ML, Bjørnvold M, Sætre E, Johannessen SI.
    Ther Drug Monit; 2020 Oct 10; 42(5):744-753. PubMed ID: 32558674
    [Abstract] [Full Text] [Related]

  • 25. Interaction of cannabidiol with other antiseizure medications: A narrative review.
    Gilmartin CGS, Dowd Z, Parker APJ, Harijan P.
    Seizure; 2021 Mar 10; 86():189-196. PubMed ID: 33541771
    [Abstract] [Full Text] [Related]

  • 26. Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam.
    Rana RR, Rajasekaran K, Knappertz V, Gray RA.
    Exp Neurol; 2023 Feb 10; 360():114286. PubMed ID: 36442674
    [Abstract] [Full Text] [Related]

  • 27. Commentary on: Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Czuczwar SJ.
    Epilepsia; 2020 Oct 10; 61(10):2063-2064. PubMed ID: 33460074
    [No Abstract] [Full Text] [Related]

  • 28. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC, Bebin EM, Checketts D, Chez M, Flamini R, Marsh ED, Miller I, Nichol K, Park Y, Segal E, Seltzer L, Szaflarski JP, Thiele EA, Weinstock A, CBD EAP study group.
    Epilepsy Res; 2019 Aug 10; 154():13-20. PubMed ID: 31022635
    [Abstract] [Full Text] [Related]

  • 29. Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.
    Devinsky O, Thiele EA, Wright S, Checketts D, Morrison G, Dunayevich E, Knappertz V.
    Acta Neurol Scand; 2020 Dec 10; 142(6):531-540. PubMed ID: 32592183
    [Abstract] [Full Text] [Related]

  • 30. Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy.
    Georgieva D, Langley J, Hartkopf K, Hawk L, Margolis A, Struck A, Felton E, Hsu D, Gidal BE.
    Epilepsy Behav; 2023 Apr 10; 141():109159. PubMed ID: 36893722
    [Abstract] [Full Text] [Related]

  • 31. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
    Isojarvi J, Gidal BE, Chung S, Wechsler RT.
    Epilepsy Behav; 2018 Jan 10; 78():149-154. PubMed ID: 29202277
    [Abstract] [Full Text] [Related]

  • 32. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW, Isojarvi J, Lee D, Drummond R, Benbadis SR.
    Epilepsy Behav; 2014 Dec 10; 41():47-52. PubMed ID: 25282105
    [Abstract] [Full Text] [Related]

  • 33. A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children.
    Ogungbenro K, Aarons L, CRESim & Epi-CRESim Project Groups.
    Pharm Res; 2015 Jan 10; 32(1):144-57. PubMed ID: 25052507
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y, Ohtsuka Y, STP-1 Study Group.
    Epilepsy Res; 2014 May 10; 108(4):725-31. PubMed ID: 24630050
    [Abstract] [Full Text] [Related]

  • 35. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE, Szaflarski JP.
    Curr Neurol Neurosci Rep; 2018 Sep 08; 18(11):73. PubMed ID: 30194563
    [Abstract] [Full Text] [Related]

  • 36. Is adjunctive Cannabidiol effective in controlling seizures for adult patients with Lennox-Gastaut Syndrome? - A single centre long term follow up study.
    Elbadri M, Bose S, Elkider M, Hayton T, McCorry D, Sumangala S, Wysota B, Samarasekera S.
    Epilepsy Behav; 2024 Aug 08; 157():109904. PubMed ID: 38908033
    [Abstract] [Full Text] [Related]

  • 37. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR.
    Lancet Neurol; 2016 Mar 08; 15(3):270-8. PubMed ID: 26724101
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
    Jullien V, Chhun S, Rey E, Dulac O, Tod M, Chiron C, Pons G.
    Clin Pharmacokinet; 2015 May 08; 54(5):527-36. PubMed ID: 25503589
    [Abstract] [Full Text] [Related]

  • 39. Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy.
    Peigné S, Chhun S, Tod M, Rey E, Rodrigues C, Chiron C, Pons G, Jullien V.
    Clin Pharmacokinet; 2018 Jun 08; 57(6):739-748. PubMed ID: 28819726
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
    Savage TE, Sourbron J, Bruno PL, Skirvin LA, Wolper ES, Anagnos CJ, Thiele EA.
    Epilepsy Res; 2020 Feb 08; 160():106263. PubMed ID: 31923763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.